Cardiff Oncology

CRDF · NASDAQ

$0.9315+$0.0685 (+7.94%)TodayMarket closed ·
Prev close $0.863

Who owns CRDF

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 19.8% of CRDF’s shares.

  • Laurion Capital Management LP4.0%
  • Vanguard Capital Management, LLC3.7%
  • Pfizer Inc.3.1%
  • Pace (Gary William)2.6%
  • Next 6 largest institutions6.3%
  • All other shareholders80.2%
Top institutional holders of CRDF
HolderShares% of shares
Laurion Capital Management LP3.10M3.98%
Vanguard Capital Management, LLC2.90M3.72%
Pfizer Inc.2.41M3.10%
Pace (Gary William)2.04M2.63%
Franklin Advisers, Inc.1.21M1.55%
BlackRock Institutional Trust Company, N.A.915.55K1.18%
William Blair & Company, L.L.C. (Research)912.51K1.17%
Geode Capital Management, L.L.C.820.06K1.05%
Jane Street Capital, L.L.C.607.90K0.78%
UBS Switzerland AG465.27K0.60%

Largest mutual fund holders

Top mutual fund holders of CRDF
HolderShares% of shares
Vanguard Total Stock Market Index Fund2.07M2.66%
Franklin Templeton Investment Funds -Biotechnology Discovery766.68K0.99%
Vanguard Extended Market Index Fund759.32K0.98%
Franklin Biotechnology Discovery Fund438.96K0.56%
Fidelity Extended Market Index Fund353.99K0.45%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders bought $1.12M (4 trades) of CRDF on the open market, with no sales.

Latest CRDF insider transactions
InsiderTypeSharesValue
Mohindru ManiBuy34.36K—
Mohindru ManiBuy34.36K$50.00K
PACE GARY WBuy687.28K—
PACE GARY WBuy687.28K$1000.00K
Mohindru ManiBuy24.70K$29.89K
PACE GARY WBuy30.00K$36.60K
White LaleAward40.56K—
TANNENBAUM RENEE PAward40.56K—
Markin Rodney SAward40.56K—
Armitage James OAward40.56K—

Short interest

Settled Sep 30, 2026

Shares short
12.07M
Days to cover
17.19
% of shares outstanding
15.52%
Average daily volume
702.32K
Change since last report
−1.9%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.